Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Complementary and countervailing actions of Jak2 and Ikk2 in hematopoiesis in mice

Experimental Hematology(2023)10.1016/j.exphem.2023.08.005Source: DataRank Database

Complementary and countervailing actions of Jak2 and Ikk2 in hematopoiesis in mice is a research paper published in Experimental Hematology (2023). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.33)OA: bronzeTopics (37)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Angelo B. A. Laranjeira ORCID,Tim Kong,Steven C. Snyder,Kevin G. Shim ORCID,Mary C. Fulbright

Live enrichment

PubMed:37611729 PMC:PMC11227100 OpenAlex:https://openalex.org/W4386035313

NHLBI NIH HHS

Grant: K08 HL106576

NCI NIH HHS

Grant: P30 CA091842

NHLBI NIH HHS

Grant: R01 HL134952

NHLBI NIH HHS

Grant: T32 HL007088

FWCI

0.33

Citation Percentile

0.6%

Citation Trend

2025

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.exphem.org/article/S0301472X23016739/pdf

publisherhttp://www.exphem.org/article/S0301472X23016739/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0301472X23016739?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0301472X23016739?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.exphem.2023.08.005

Fields of Study

Myeloproliferative Neoplasms: Diagnosis and TreatmentAcute Myeloid Leukemia ResearchCytokine Signaling Pathways and InteractionsMiceHumansAnimalsPolycythemia VeraJanus Kinase 2Myeloproliferative DisordersMutationHematopoietic Stem CellsHematopoiesisProtein Serine-Threonine Kinases

MeSH Terms

AnimalsHematopoiesisHematopoietic Stem CellsHumansMutationMyeloproliferative DisordersPolycythemia VeraProtein Serine-Threonine KinasesMiceJanus Kinase 2

Keywords

HaematopoiesisMyeloidBiologyStem cellHematopoietic stem cellJAK2 V617FCancer researchJanus kinase 2Progenitor cellCell biologyMutationGeneticsGeneKinase

Sustainable Development Goals

SDG 0: Good health and well-being